ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1260 • ACR Convergence 2025

    Increasing Zoster Vaccination Rates in Immunosuppressed Veterans at the North Texas VA Medical Center Rheumatology Clinic

    Benjamin Gardner1, Ankitha Lingamaneni2, Isabel Penabad3, Jiby Mathew4, Una Makris5, Rashmi Arora6, Swathi Reddy7 and Nagendra Pokala8, 1UTSW, Dallas, TX, 2University of Texas Southwestern Medical Center, Dallas, TX, 3UT Southwestern, Dallas, TX, 4Veteran's Affairs, Rowlett, TX, 5UT Southwestern Medical Center and Dallas VA, Dallas, TX, 6VA north texas health centre Dallas, Dallas, TX, 7UT Southwestern Medical Center / Dallas VA Medical Center, Colleyville, TX, 8Veterans Affairs North Texas Healthcare System, Dallas, TX

    Background/Purpose: Shingles is a painful cutaneous eruption due to the reactivation of latent Varicella zoster virus. Immunocompromised adults, due to a medical condition or immunosuppressive…
  • Abstract Number: 1309 • ACR Convergence 2025

    Transcriptomic biomarkers of progression from undifferentiated arthritis to rheumatoid arthritis

    Christina Printzis1, Keerthana Nagesh Prabhu2, Regina Sakalyte3, Sigita Stropuviene3 and Damini Jawaheer1, 1Northwestern University, Chicago, IL, 2Washington University in St. Louis, St Louis, MO, 3Vilnius University, Faculty of Medicine, Institute of Clinical Medicine, Clinic of Rheumatology, Orthopedics Traumatology and Reconstructive Surgery, Vilnius, Lithuania

    Background/Purpose: A broad range (6-55%) of patients classified as having undifferentiated arthritis (UA) tend to progress to rheumatoid arthritis (RA), suggesting that UA in these…
  • Abstract Number: 1312 • ACR Convergence 2025

    Evolution of patients with active rheumatoid arthritis: analysis of disease activity trajectories in a tertiary‑care rheumatology department

    Elodie Portier1, Olivier Fogel2, Terkia Medkour3, Sophie Hecquet3 and Jérôme AVOUAC3, 1Rheumatology department, Bicetre hospital, Le Kremlin Bicetre, France, 2AP-HP, Paris, France, 3Rheumatology department, Cochin hospital, Paris, France

    Background/Purpose: The objective of this study was to identify clusters of patients with rheumatoid arthritis (RA) in clinical practice, according to evolution of disease activity…
  • Abstract Number: 1310 • ACR Convergence 2025

    Naturalized Language Processing Based Extraction of Rheumatoid Arthritis Disease Activity Measures from the Electronic Health Record

    Elizabeth Park1, Iram Kamdar2, Reid Weisberg1, Andy Nguyen1, Joan Bathon3, Jon Giles4, Chunhua Weng5 and Elana Bernstein1, 1Columbia University Irving Medical Center, New York, NY, 2Columbia University Data Science Institute, New York, NY, 3Columbia University, NEW YORK, NY, 4Cedars-Sinai Medical Center, New York, NY, 5Columbia University Department of Biomedical Informatics, New York, NY

    Background/Purpose: A treat-to-target approach in rheumatoid arthritis (RA) requires intense monitoring of RA disease activity with measures such as the clinical disease activity index (CDAI).…
  • Abstract Number: 1367 • ACR Convergence 2025

    Molecular Signature Response Classifier Identifies Contribution of GLP-1 Therapy to TNF Inhibitor Response in Rheumatoid Arthritis Patients

    Lixia Zhang1, Angus Wong2, Alex Jones2, Sherry Guardiano2, Reginald Seeto2 and Ryan T, Phan3, 1Scipher Medicine, Plainsboro, NJ, 2Scipher Medicine, Waltham, 3Scipher Medicine, Los Gatos

    Background/Purpose: Tumor necrosis factor-α inhibitors (TNFi) are extensively utilized in the management of rheumatoid arthritis (RA). Therapeutic responses remain highly heterogeneous. Emerging evidence suggests glucagon-like…
  • Abstract Number: 1393 • ACR Convergence 2025

    Prevalence of Sjögren’s Disease in the United States – A Retrospective Cohort Study Among a Commercially Insured Population (2019-2023)

    Minoti Ganguli, Annie Kilby, Ahva Shahabi and Tsu-Chieh Jay Lin, Amgen Inc., Thousand Oaks, CA

    Background/Purpose: Sjögren’s disease (SjD) is a systemic autoimmune condition characterized by diverse clinical manifestations, which often complicates diagnosis and disease management1. Previous epidemiological estimates of…
  • Abstract Number: 1270 • ACR Convergence 2025

    Increasing Participation in the FT819 Cell Therapy Trial Amongst People Living with Lupus: A Focus Group Study

    Joy Buie1, Safoah Agyemang1, Andrew Henry2, Andrew BitMansour3, Vaneet Sandhu4, Debra Zack5 and Michael Fisher1, 1Lupus Foundation of America, Washington, DC, 2Fate Therapeutics, Inc., San Diego, CA, 3Fate Therapeutics, Inc., San Carlos, CA, 4Fate Therapeutics, Inc., San Diego, 5Fate Therapeutics, San Diego

    Background/Purpose: Clinical trials exploring the safety and efficacy of chimeric antigen receptor (CAR) T-cell therapy for lupus are growing. Challenges linked to recruitment for CAR…
  • Abstract Number: 1278 • ACR Convergence 2025

    Differences in Patient and Provider Perception of Functional Status in Adolescents with Lupus

    Emily Masi1, Kimberly Rapoza2, Tamar Rubinstein3, Kathy Kenney-Riley4 and Joyce Hui-Yuen5, 1Cohen Children's Medical Center, North New Hyde Park, NY, 2Mercy College, Dobbs Ferry, NY, 3Albert Einstein College of Medicine, White Plains, NY, 4Mercy University, Dobbs Ferry, NY, 5North Shore LIJ Health System, Great Neck, NY

    Background/Purpose: Patient and provider discordance can negatively impact medication adherence and disease outcomes in pediatric lupus. Functional status is known to greatly affect perception of…
  • Abstract Number: 1286 • ACR Convergence 2025

    Response to Hydroxychloroquine in Immune Thrombocytopenia in Childhood-Onset Systemic Lupus Erythematosus

    Hamada Natour1, Y. Ingrid Goh1, Daniela Dominguez2, Nicholas Gold1, Lawrence Ng3, Andrea Knight4, Earl Silverman1, Brian Feldman1, Linda Hiraki1 and Deborah Levy1, 1The Hospital for Sick Children, Toronto, ON, Canada, 2The Hospital for Sick Children, Toronto, Canada, 3The Hospital for Sick Children, Toronto, Canada, Toronto, ON, Canada, 4Hospital for Sick Children, Toronto, ON, Canada

    Background/Purpose: The management of immune thrombocytopenia in childhood-onset systemic lupus erythematosus (cSLE) is not standardized. We examined the efficacy and safety of hydroxychloroquine (HCQ) as…
  • Abstract Number: 1395 • ACR Convergence 2025

    A Comparative Study of Yao Syndrome and Primary Sjögren’s Syndrome

    Nayaab Bakshi1, Christopher Loh2, Song Wu3 and Qingping Yao3, 1Stony Brook University, Dix Hills, NY, 2Stony Brook University, Lake Grove, NY, 3Stony Brook University, Stony Brook, NY

    Background/Purpose: Yao syndrome (YAOS, OMIM 617321) is formerly named Nucleotide-binding oligomerization domain containing protein 2 (NOD2)-associated autoinflammatory disease affecting multiorgan systems characterized by recurrent fever,…
  • Abstract Number: 1405 • ACR Convergence 2025

    A Combined Score of Syndesmophytes and Facet Joint Ankylosis Improves Sensitivity to Spinal Structural Damage Progression in Axial Spondyloarthritis

    Ana Bento da Silva1, Floris A. van Gaalen1, Robert Landewé2, Manouk de Hooge3, Mary Lucy Marques4, Miranda van Lunteren1, Liese de Bruin1, Gizem Ayan5, Xenofon Baraliakos6, Monique Reijnierse7, Jürgen Braun8, Désirée Van Der Heijde1 and Sofia Ramiro9, 1Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Department of Rheumatology, Amsterdam University Medical Center, Amsterdam, Netherlands; and Zuyderland Medical Center, Heerlen, Netherlands, 3Department of Rheumatology, Ghent University Hospital, Ghent, Belgium, 4Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands; and Coimbra Local Health Unit, Coimbra, Portugal, 5Ankara Research and Training Hospital, Ankara, Turkey, 6Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 7Department of Radiology, Leiden University Medical Center, Leiden, Netherlands, 8Ruhr-University, Bochum, Germany; and Rheumatologische Versorgungszentrum (RVZ) Steglitz, Berlin, Germany, 9Leiden University Medical Center, Bunde, Netherlands

    Background/Purpose: The computed tomography (CT) syndesmophyte score (CTSS) has shown to be more sensitive in capturing spinal structural damage progression in axial SpA (axSpA), compared…
  • Abstract Number: 1408 • ACR Convergence 2025

    When Damage and Disability Diverge: Unraveling Sex-Based Drivers of Axial Spondyloarthritis Burden

    Claudia Marques1, Gustavo Resende2, Carla Saad3, Adriana Marinho4, Andressa Soares5, Beatriz Paiva6, Cleandro Pires7, Débora Rodrigues8, Glaucio Castro9, Guilherme Bulbol10, Jamile Carneiro11, Manuella Ochtrop12, José Mauro Fernandes13, Maria Bernadete Gavi14, Maria Eduarda Veiga3, Michel Yazbek15, Nara Cavalcanti16, Natalia Machado17, Olivio Malheiro18, Rafael Bassara Macedo19, Rejane Vieira20, Ricardo Lage18, Rita Menin21, Rywka Golebiovski22, Sandra Ribeiro10, Thauana Oliveira22, Valquiria Diniz14, Percival Sampaio-Barros23 and Marcelo Pinheiro24, 1Hospital das Clinicas - Universidade Federal de Pernambuco - UFPE, Recife, Pernambuco, Brazil, 2Hospital das Clinicas UFMG, Belo Horizonte, Brazil, 3Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil, Sao Paulo, Brazil, 4Fundação Hospital do Acre - AC, Rio Branco, Brazil, 5Hospital Universitário da Universidade Federal de Santa Catarina (UFSC) - SC, Florianópolis, Brazil, 6Faculdade de Medicina da Universidade Federal do Amazonas (UFAM) - AM, Manaus, Brazil, 7UNB, Brasilia, Distrito Federal, Brazil, 8Fundação Hospital do Acre - AC, Rio Branco, Acre, Brazil, 9Hospital Governador Celso Ramos (HCR) - SC, Florianópolis, Santa Catarina, Brazil, 10Faculdade de Medicina da Universidade Federal do Amazonas (UFAM) - AM, Manaus, Amazonas, Brazil, 11Hospital de Base do Distrito Federal (HBDF) - DF, Brasilia, Distrito Federal, Brazil, 12Hospital Universitário Pedro Ernesto / UERJ - RJ, Rio de Janeiro, Rio de Janeiro, Brazil, 13Universidade Federal do Maranhão (UFMA) - MA, São Luiz, Maranhao, Brazil, 14Universidade Federal do Espírito Santo (UFES) - ES, Vitória, Espirito Santo, Brazil, 15Universidade Estadual de Campinas (UNICAMP) - SP, Campinhas, Sao Paulo, Brazil, 16Hospital das Clínicas da Universidade Federal de Pernambuco (UFPE) - PE, Recife, Pernambuco, Brazil, 17Universidade Fedral do Paraná (UFPR) - PR, Curitiba, Parana, Brazil, 18Hospital das Clínicas da Universidade Federal de Minas Gerais (UFMG) - MG, Belo Horizonte, Minas Gerais, Brazil, 19Rheumatology Division, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil, 20Universidade Estadual do Ceará (UECE) - CE, Fortaleza, Ceara, Brazil, 21Faculdade de Medicina de São José do Rio Preto (FAMERP) - SP, São José do Rio Preto, Sao Paulo, Brazil, 22Escola Paulista de Medicina (EPM) - Universidade Federal de São Paulo (UNIFESP) - SP, São Paulo, Sao Paulo, Brazil, 23Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil, São Paulo, Brazil, 24UNIFESP/ EPM, São Paulo, São Paulo, Brazil

    Background/Purpose: Sex differences in axial spondyloarthritis (axSpA) are well recognized, but their clinical consequences remain understudied in real-world settings. This study aimed to assess sex-based…
  • Abstract Number: 1281 • ACR Convergence 2025

    Ethnic Disparities in Mental Health Screening, Diagnoses, and Outcomes in Patients with Childhood-Onset Systemic Lupus Erythematosus

    Alicia Tran1, Indrani Das2, Zhaoyu Ding3, Daniela Dominguez4, Sefi Kronenberg5, Lawrence Ng6, Alene Toulany1, Gwyneth Zai7, Deborah Levy1, Andrea Knight8 and Linda Hiraki1, 1The Hospital for Sick Children, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3SickKids Research Institute, Toronto, ON, Canada, 4The Hospital for Sick Children, Toronto, Canada, 5Holland Bloorview Kids Rehabilitation Hospital, Toronto, ON, Canada, 6The Hospital for Sick Children, Toronto, Canada, Toronto, ON, Canada, 7Centre for Addiction & Mental Health, Toronto, ON, Canada, 8Hospital for Sick Children, Toronto, ON, Canada

    Background/Purpose: Patients with childhood-onset systemic lupus erythematosus (cSLE) face higher risks of depression and anxiety compared to healthy peers. In 2022, standardized mental health (MH)…
  • Abstract Number: 1319 • ACR Convergence 2025

    The Association of Rheumatoid Arthritis in Patients with Vitiligo: Systematic Review and Meta-Analysis

    Nattanicha Chaisrimaneepan1, thunyaporn Khoruamklang2, Pitchaporn Yingchoncharoen3, Tulaton Sodsri4 and Miriam Paz3, 1Texas Tech University Health Sciences Center, Lubbock, TX, 22Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, bangkok, Thailand, 3Texas Tech University Health Sciences Center, Lubbock, 4Department of Medicine, Texas Tech University Health Sciences Center, Bangkok, Thailand

    Background/Purpose: Vitiligo is associated with many autoimmune diseases, but its association with rheumatic disease has not been well-defined. Therefore, we conducted a systematic review and…
  • Abstract Number: 1252 • ACR Convergence 2025

    Can LLMs Categorize Patient Priorities Like Humans? Comparing AI and Human Coders in Arthritis Nominal Group Discussions

    Melissa Mannion1, Bryce Thornton1, Bella Mehta2, Ronan O'Beirne1, Emily Smitherman1, Livie Timmerman3, Shilpa Venkatachalam4, Jeffrey Curtis1 and John Osborne1, 1University of Alabama at Birmingham, Birmingham, AL, 2Hospital for Special Surgery, Weill Cornell Medicine, Jersey City, NJ, 3University of Alabama at Birmingham, Gardendale, AL, 4Global Healthy Living Foundation, New York, NY

    Background/Purpose: Identifying informational needs of individuals with inflammatory arthritis is critical to enhancing communication and supporting shared decision making between patients, caregivers, and providers. However,…
  • « Previous Page
  • 1
  • …
  • 111
  • 112
  • 113
  • 114
  • 115
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology